Clear + Brilliant Laser System (1440nm and 1927nm handpieces) is indicated for dermatological procedures requiring the coagulation of soft tissue and general skin resurfacing.
The following contraindications are routine for many laser treatments and may also be associated with non-ablative Clear + Brilliant Laser System treatments. You may not be an appropriate candidate for a treatment if you:
Talk to your doctor for more information about Clear + Brilliant, and see www.clearandbrilliant.com for additional details.
The Clear + Brilliant laser was developed by Solta Medical – the pioneers of fractional laser treatments with a proven history of over five million treatments. Designed with powerfully precise laser energy to stimulate a collagen boost, Clear + Brilliant quickly and effectively treats the signs of aging to reveal more youthful looking skin.
Clear + Brilliant was not only designed to be effective, but also to be comfortable. The system's smart-tip technology and advanced precision energy system ensures excellent results with little to no social downtime.
Clear + Brilliant can be used on all skin types but some side effects may occur. Your treatment provider will perform a pre-treatment consultation and decide with you if Clear + Brilliant is the right choice for you. Read More about Clear + Brilliant important safety information.
Indications for Use
The Clear + Brilliant Laser System is indicated for use in aesthetic procedures requiring the coagulation of soft tissue, as well as for general skin resurfacing procedures.
In the skin, water is the primary absorber (chromophore) of the laser wavelengths used by Clear + Brilliant. It can be safely used on all skin types.
Clear + Brilliant includes an Intelligent Optical Tracking™ System (IOTS) that senses skin contact with the treatment tip rollers, and the motion of the tip relative to the skin surface. This feature ensures safety and uniform treatment delivery.
Your treatment provider will perform a pre-treatment consultation and decide, together with you, if Clear + Brilliant is adequate for you and your unique treatment needs.
Not all individuals will necessarily react the same way to the laser treatment.
The following (but not limited to) contraindications are routine for many laser treatments and may also be associated with Clear + Brilliant. Your provider will perform a pre-screening and request you to sign a consent including these (but not limited to) contraindications:
Solta Medical Inc. has no clinical information or experience concerning the use of Clear + Brilliant on pregnant women or nursing mothers.
*Accutane brand no longer available.
For treatments associated with Clear + Brilliant, new skin (epithelium) will start to form within 24 hours but will remain covered by the old superficial layer of the skin (stratum corneum). This new skin formation usually lasts about 4 days, but can be longer for some skin types. During that time, the skin's natural exfoliation process will reveal the newly repaired skin tissue. You can protect it by avoiding aggressive mechanical exfoliation and by applying moisturizers and sunscreen frequently.
Sun exposure before and during treatment can increase the risk of unwanted pigmentation. After treatment the skin is more sensitive to the sun, which can increase the risk of unwanted pigmentation and sunburn. Post-treatment, individuals should plan to use a high SPF sunscreen on a regular basis. Ideally, a dual UVA/UVB sunscreen should be applied containing a physical sun block (either or both zinc oxide or titanium dioxide) with a sun protection factor of 15 or above. Applying sunscreen helps maintain good results. In general, direct sunlight avoidance is highly recommended as well as wearing sun-protective clothing (i.e. a wide-brimmed hat) whenever possible.
Routine Skin Care
Most skin care products can be used the day after treatment. Avoid the use of retinoids and topical corticosteroids for 1 – 2 weeks before and after treatment. Avoid systemic steroids (i.e., prednisone, dexamethasone) throughout the course of the Clear + Brilliant treatment.
© 2017 Valeant Pharmaceuticals North America LLC. All Rights Reserved. CBT.0026.USA.16